期刊文献+

Effect of a novel compound from <i>Lycopodium obscurum</i>L. on osteogenic activity of osteoblasts in <i>vitro</i>

Effect of a novel compound from <i>Lycopodium obscurum</i>L. on osteogenic activity of osteoblasts in <i>vitro</i>
下载PDF
导出
摘要 We investigated the potential of an extract of Lycopodium obscurum L.;stigmastane-3-oxo- 21-oic acid (SA), to enhance osteogensis of mouse osteoblastic MC3T3-E1 cells. SA at a concentration of 16 μM was found to have no significant effect upon the viability of the cells, thus concentrations of 8 μM and 16 μM of SA were used in all further experiments. Both concentrations of SA had an inhibitory affect upon alkaline phosphatase activity (ALP) after 8 days incubation, however, after 16 days activity was restored to control levels. However Alizarin red S staining showed increased levels of mineralization for both concentrations after 16 days culture. Real time PCR showed inhibition of genes Runx2 and Osterix genes responsible for the up-regulation of ALP. However early time point (8 days) up-regulation of bone matrix mineralization genes OPN and OCN, and late time point (16 days) up-regulation of both Jun-D and Fra-2 mRNA expression was significantly enhanced. These results suggest a potential mechanism of SA in enhancing bone fracture healing is through the up-regulating bone matrix mineralization. We investigated the potential of an extract of Lycopodium obscurum L.;stigmastane-3-oxo- 21-oic acid (SA), to enhance osteogensis of mouse osteoblastic MC3T3-E1 cells. SA at a concentration of 16 μM was found to have no significant effect upon the viability of the cells, thus concentrations of 8 μM and 16 μM of SA were used in all further experiments. Both concentrations of SA had an inhibitory affect upon alkaline phosphatase activity (ALP) after 8 days incubation, however, after 16 days activity was restored to control levels. However Alizarin red S staining showed increased levels of mineralization for both concentrations after 16 days culture. Real time PCR showed inhibition of genes Runx2 and Osterix genes responsible for the up-regulation of ALP. However early time point (8 days) up-regulation of bone matrix mineralization genes OPN and OCN, and late time point (16 days) up-regulation of both Jun-D and Fra-2 mRNA expression was significantly enhanced. These results suggest a potential mechanism of SA in enhancing bone fracture healing is through the up-regulating bone matrix mineralization.
出处 《Natural Science》 2013年第1期84-92,共9页 自然科学期刊(英文)
关键词 OSTEOGENESIS RT-PCR Osteogenesis RT-PCR
  • 相关文献

参考文献2

二级参考文献39

  • 1郑海兴.伸筋草煎剂对小鼠抗炎镇痛药理实验研究[J].牡丹江医学院学报,2005,26(2):10-12. 被引量:35
  • 2冯毅凡,郭晓玲,韩亮.伸筋草挥发性成分GC-MS分析[J].广东药学院学报,2005,21(5):515-516. 被引量:8
  • 3贺立中.用两步超滤法制备伸筋草注射液的实验研究[J].中草药,1996,27(12):719-721. 被引量:28
  • 4钱信忠.中国本草彩色图鉴[M].北京:人民卫生出版社,2003.459-459.
  • 5Aubin J E,Triffitt J T.Mesenchymal stem cells and osteoblast differentiation.In:Bilezikian J P,eds.Principles of Bone Biology.London:Academic Press,2002.59~81
  • 6Yamaguchi A,Komori T,Suda T.Regulation of osteoblast differentiation mediated by bone morphogenetic proteins,hedgehogs,and Cbfa1.Endocr Rev,2000,21 (4):393~411
  • 7Komori T,Yagi H,Nomura S,et al.Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest ofosteoblasts.Cell,1997,89 (5):755~764
  • 8Otto F,Thornell A P,Crompton T,et al.Cbfa1,a candidate gene for cleidocranial dysplasia syndrome,is essential for osteoblast differentiation and bone development.Cell,1997,89 (5):765~771
  • 9Mundlos S,Otto F,Mundlos C,et al.Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.Cell,1997,89 (5):773~779
  • 10Ducy P,Zhang R,Geoffroy V,et al.Osf2/Cbfa1:a transcriptional activator of osteoblast differentiation.Cell,1997,89 (5):747~754

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部